The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
D000588:Amines / Q000032:analysis*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects*; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D010134:Fenclonine / Q000494:pharmacology; D008297:Male; D008704:Methazolamide / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism
D000588:Amines; D000927:Anticonvulsants; D002257:Carbonic Anhydrase Inhibitors; D008781:Methyltyrosines; D012701:Serotonin; D010672:Phenytoin; D012110:Reserpine; D010134:Fenclonine; D004298:Dopamine; D008704:Methazolamide; D009638:Norepinephrine